August 17, 2009 (FinancialWire) — MAKO Surgical Corp. (NASDAQ: MAKO), a medical device company that markets both its RIO(r) robotic arm interactive orthopedic surgical platform and proprietary RESTORIS(r) implants for minimally invasive orthopedic knee procedures known as MAKOplasty(r), announced that it intends to offer shares of its common stock in a public offering. Piper Jaffray & Co. is acting as the sole book-running manager for the offering and Leerink Swann LLC is acting as co-manager.

This offering is being made pursuant to a shelf registration statement filed with the Securities and Exchange Commission on May 18, 2009, which became effective on May 26, 2009. A prospectus supplement relating to the offering will be filed with the Securities and Exchange Commission.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.